The molecular-based classification of medulloblastoma into WNT activated, SHH activated, group 3, and group 4 opened the door for research endeavors that aim to study the specific cellular, molecular, and neurodevelopmental characteristics of each subtype. This evidence concerns the gene SHH and medulloblastoma.